Trial Profile
Characteristics of Alzheimer's Disease Patients Switching from Memantine HCl Immediate-Release Tablets to Memantine HCl Extended-Release Tablets: A Retrospective Analysis of Administrative Claims
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2015
Price :
$35
*
At a glance
- Drugs Memantine (Primary) ; Memantine
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 14 Oct 2015 New trial record